#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14192	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2147	656.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1457	1457	C	804	C,A	768,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14192	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2147	656.8	0	HET	.	.	.	A198G	.	198	198	A	471	471	A	765	A,G	540,184	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25178	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3490	718.7	0	.	n	.	0	T695C	SNP	695	695	T	1003	1003	C	789	C	740	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25178	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3490	718.7	0	.	n	.	0	A1638G	SNP	1638	1638	A	1946	1946	G	835	G,A	791,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25178	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3490	718.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2279	2279	C	770	C,T	721,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25178	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3490	718.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2353	2353	A	784	A	749	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25178	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3490	718.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2905	2905	C	766	C	721	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1892	folP	855	855	100.0	folP.l15.c4.ctg.1	1699	111.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1201	1203	AGC	200;196;198	A;G;C	192;188;188	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4872	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3522	138.1	1	SNP	p	S91F	1	.	.	271	273	TTC	698	700	TTC	178;178;178	T;T,C;C	169;170,1;170	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4872	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3522	138.1	1	SNP	p	D95G	1	.	.	283	285	GGC	710	712	GGC	174;171;171	G;G,A;C	169;164,1;162	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4872	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3522	138.1	1	SNP	p	G95N	0	.	.	283	285	GGC	710	712	GGC	174;171;171	G;G,A;C	169;164,1;162	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1596	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1305	121.6	1	SNP	p	G45D	0	.	.	133	135	GGC	413	415	GGC	184;182;183	G;G;C,T	172;170;169,1	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	744	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1138	65.3	0	.	n	.	0	A197.	DEL	197	197	A	620	620	A	166	A	151	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5484	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2948	185.1	1	SNP	p	D86N	0	.	.	256	258	GAC	617	619	GAC	231;230;232	G,T;A;C	218,1;215;220	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5484	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2948	185.1	1	SNP	p	S87R	1	.	.	259	261	CGT	620	622	CGT	231;231;233	C;G;T	219;217;219	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5484	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2948	185.1	1	SNP	p	R87W	0	.	.	259	261	CGT	620	622	CGT	231;231;233	C;G;T	219;217;219	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5484	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2948	185.1	1	SNP	p	R87I	0	.	.	259	261	CGT	620	622	CGT	231;231;233	C;G;T	219;217;219	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5484	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2948	185.1	1	SNP	p	S88P	0	.	.	262	264	TCC	623	625	TCC	232;231;228	T;C;C	219;220;217	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3910	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2758	141.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1603	1605	GGC	212;212;209	G;G;C	200;197;196	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3678	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2340	156.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1237	1239	GCC	184;184;185	G,A;C;C	167,1;170;171	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3678	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2340	156.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1240	1242	ATG	185;182;177	A;T;G	172;169;163	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3678	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2340	156.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1252	1254	ACC	179;179;180	A,G;C;C	169,1;173;172	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3678	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2340	156.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1252	1254	ACC	179;179;180	A,G;C;C	169,1;173;172	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3678	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2340	156.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1753	1755	ACC	218;219;217	A;C;C	201;205;202	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3678	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2340	156.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1807	1809	GCG	189;190;192	G;C;G	181;179;181	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3678	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2340	156.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1807	1809	GCG	189;190;192	G;C;G	181;179;181	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3678	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2340	156.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1930	1932	GGT	155;152;151	G;G;T	147;145;144	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3678	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2340	156.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1939	1941	AGC	145;147;147	A;G;C	136;137;135	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3678	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2340	156.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1957	1959	CCG	141;144;146	C,G;C,G;G	106,7;112,1;116	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5356	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3039	175.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1612	1614	CCG	196;195;199	C;C;G	176;182;185	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2312	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1783	128.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	508	508	C	181	C	170	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2752	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1691	162.2	1	SNP	p	G120K	1	.	.	358	360	AAG	679	681	AAG	209;209;212	A;A;G,T	192;193;192,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2752	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1691	162.2	1	SNP	p	A121N	1	.	.	361	363	AAC	682	684	AAC	208;204;202	A,G;A;C	189,1;188;188	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2752	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1691	162.2	1	SNP	p	N121D	0	.	.	361	363	AAC	682	684	AAC	208;204;202	A,G;A;C	189,1;188;188	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9756	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4855	200.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	998	rpsJ	312	312	100.0	rpsJ.l6.c17.ctg.1	1101	90.1	1	SNP	p	V57M	1	.	.	169	171	ATG	516	518	ATG	177;176;176	A;T;G	167;165;165	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
